Capivasertib inhibits a key pathway in metastatic breast cancer. Nasrazadani A, Brufsky AM. Lancet Oncol 2020 Feb 5. pii: S1470-2045(19)30857.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nasrazadani A, Brufsky AM. Capivasertib inhibits a key pathway in metastatic breast cancer. Lancet Oncol 2020 Feb 5. pii: S1470-2045(19)30857.
PMID: 32035019